What Researchers Did
Researchers conducted a multicenter prospective study comparing hyperbaric oxygen therapy plus iloprost to a historical cohort receiving iloprost alone for severe frostbite.
What They Found
The prospective cohort (28 patients) receiving HBO plus iloprost had a significantly higher mean number of preserved segments per patient (13 ± 10) compared to the historical cohort (30 patients) receiving iloprost alone (6 ± 5, p = 0.006). The odds of preserving segments were 45-fold higher (95%CI: 6-335, p < 0.001) in the HBO plus iloprost group.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in a cross-border program among hyperbaric centers in Geneva, Lyon, and Mont-Blanc hospitals.
Study Limitations
A significant limitation is the comparison to a historical cohort rather than a concurrently randomised control group, which introduces potential biases.